Base Drug Prices On Value Rather Than R&D

For decades, R&D spending on pharmaceuticals has gone up more or less in tandem with the list prices of prescription drugs. Pharmaceutical companies sometimes cite rising R&D expenditures to justify list prices of prescription drugs in the U.S.